Feeds:
Posts
Comments

Archive for the ‘Facet Biotech Corporation (NASDAQ:FACT)’ Category

Absolute Return interviews Seth Klarman

Posted in Facet Biotech Corporation (NASDAQ:FACT), Seth Klarman, tagged , , , on June 7, 2010 | 8 Comments »

In The value of Seth Klarman (free registration required), Absolute Return has a rare interview with the president and portfolio manager of the 28-year-old Baupost Group. In the interview, Klarman discusses several of Baupost’s positions over the last twelve months, including the fund’s stake in Facet Biotech, which I fumbled last year: Around the same [...]

Read Full Post »

Facet Biotech Corporation (NASDAQ:FACT) alternate slate withdrawn; Greenbackd exits

Posted in Activist Investors, Facet Biotech Corporation (NASDAQ:FACT), Robert. L. Chapman, Seth Klarman, Special Situation, Stocks, tagged , on May 7, 2009 | 4 Comments »

Dr. Roderick Wong has withdrawn his slate of director nominees for election at Facet Biotech Corporation’s (NASDAQ:FACT) 2009 annual meeting of stockholders. Wong’s withdrawal means that our investment thesis is gone, and we’re closing the position. We opened the position at $9.13 and closed it at $8.96, which means we’re down 1.86% on an absolute [...]

Read Full Post »

Special situation: Facet Biotech Corporation (NASDAQ:FACT)

Posted in Activist Investors, Baupost Group, Facet Biotech Corporation (NASDAQ:FACT), Robert. L. Chapman, Special Situation, Stocks, tagged , , , , on April 22, 2009 | 11 Comments »

Facet Biotech Corporation (NASDAQ:FACT) is a new category of investment for us: special situations. It’s an activist play with a catalyst in the form of Dr. Roderick Wong’s nomination for the annual meeting of an alternative slate of directors, including well-known activist investor Robert. L. Chapman. The dissident slate has called for a cash dividend [...]

Read Full Post »